Anne-Laure Autret-Cornet

Anne-Laure has acquired a seven-year  experience in finance and audit within Deloitte and a ten-year experience in Finance / Biotech. She joined Effimune in 2013 as Administrative and Financial Manager and upon the merger with OSE Pharma in 2016, Anne-Laure was appointed Chief Financial Officer of OSE Immunotherapeutics.

Anne-Laure Autret-Cornet graduated from ESSCA Management school and has received the certificate “Corporate Finance” from HEC Paris in 2020.